понедельник, 23 января 2017 г.

SEC Brings Enforcement Action for Disclosure Failures During Merger Talks

SEC Brings Enforcement Action for Disclosure Failures During Merger Talks


The SEC's order finds that Allergan failed to disclose in a timely manner its negotiations with potentially friendlier merger partners in the months following a tender offer from Valeant Pharmaceuticals International and co-bidders in June 2014. Allergan publicly stated in a disclosure filing that the Valeant bid was inadequate and it was not engaging in negotiations that could result in a merger.



from Biotech News